XZXiang Zhang

Xiang Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiang Zhang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • B. Hoffmann

    Department of Medical Microbiology, Turku Immunology Centre; and

    1 shared publication
  • E Šimelyte

    Turku Immunology Centre, Department of Medical Microbiology, Turku University, Turku, Finland

    1 shared publication
  • E. Šimelyte

    Department of Medical Microbiology, Turku Immunology Centre; and

    1 shared publication
  • Egle Šimelyte

    <!--label omitted: 1-->Department of Medical Microbiology, Turku Immunology Center, University of Turku, Turku, Finland

    1 shared publication
  • H. Aho

    Department of Pathology, University of Turku, Turku, Finland

    1 shared publication
  • M Rimpiläinen

    Turku Immunology Centre, Department of Medical Microbiology, Turku University, Turku, Finland

    1 shared publication

Latest Publications

  • Open Access

    Enzyme Degradation and Proinflammatory Activity in Arthritogenic and NonarthritogenicEubacterium aerofaciensCell Walls

    by Xiang Zhang, Marja Rimpiläinen, Egle Šimelyte, Paavo Toivanen

    Two almost-identical strains ofEubacterium aerofaciensisolated from the normal human gut flora were used. The cell wall (CW) of one strain with a peptidoglycan (PG) type A4α induces chronic arthritis in the rat after a single intraperitoneal injection, whereas CW of the other with PG type A4β induces only a transient acute arthritis. The CW of the arthritogenicE. aerofacienswas a twofold-more-potent stimulator of the proinflammatory cytokines tumor necrosis factor alpha (TNF-α) and monocyte chemoattractant protein 1 (MCP-1) than the nonarthritogenic CW. After degradation with mutanolysin, the capacity of the arthritogenic PG to stimulate production of TNF-α and MCP-1 was significantly increased, whereas that of the nonarthritogenic PG was significantly decreased. In other words, after enzyme degradation the arthritogenic PG had a four- to fivefold-stronger stimulatory capacity than that of the enzyme-treated nonarthritogenic PG. These findings indicate that the arthritogenicity of CW or a PG is not dependent on the enzyme resistance alone but also on how the PG fragments released by enzyme degradation stimulate the production of proinflammatory cytokines.


  • Experimental Chronic Arthritis and Granulomatous Inflammation Induced byBifidobacteriumCell Walls

    by X. Zhang, M. Rimpiläinen, B. Hoffmann, E. Šimelyte, H. Aho, P. Toivanen

    Effects of cell walls (CWs) from two almost identical strains ofBifidobacterium adolescentiswere studied in rats, using three different doses. A single i.p. injection of both CWs triggered a long‐lasting arthritis with CW degradation products present in the joint tissue. Histologically, the arthritis was characterized by inflammatory cells, synovial hyperplasia, pannus formation and bone erosion, closely resembling human rheumatoid arthritis (RA). In addition, CWs of the other strain induced a remarkable granuloma formation in the spleen and liver. Both CWs have the same peptidoglycan (PG) type A4α/β, but differ from each other in three aspects. CW of the granuloma inducing strain: firstly has more lysine and less ornithine in PG stem peptides; secondly is more resistant to lysozyme degradation, and thirdly is better retained in the spleen. All these in comparison to the other strain used. Such characteristics are associated with the capacity to induce chronic arthritis, but it remains open how crucial they are for the granuloma formation.


  • Open Access

    Characterisation of Eubacterium cell wall: peptidoglycan structure determines arthritogenicity

    by X Zhang, M Rimpiläinen, E Šimelyte, P Toivanen

    OBJECTIVE To elucidate factors involved in the arthritogenicity of bacterial cell walls. METHODS For characterisation of an arthritogenic Eubacterium aerofaciens cell wall, peptidoglycan-polysaccharide (PG-PS) polymers were isolated by removing cell wall associated proteins (CWPs), PG and PS moieties were separated, and an attempt was made to de-O-acetylate PG-PS. The cell wall ofE limosum was used as a non-arthritogenic control. The chemical composition of these cell wall preparations was analysed by gas chromatography-mass spectrometry. Also, their ability to resist lysozyme degradation and to sustain experimental chronic arthritis was tested. RESULTS The observations made with the cell wall of E aerofaciens, an anaerobic habitant of the human intestine, were compared with those reported from a pathogenicStreptococcus, showing that in both strains a complex consisting of PG-PS is required for the induction of chronic arthritis. The PS moiety most probably protects PG from enzyme degradation, allowing prolonged tissue persistence and leading to the chronic synovial inflammation. CWPs attached to PG-PS are not necessary for this function. O-Acetylation of PG, which is required for arthritogenicity of the streptococcal cell wall, seems not to be present in the arthritogenic E aerofaciens PG or only occurs to a small degree; attempts to de-O-acylate the E aerofaciens cell wall did not affect its arthritogenicity or lysozyme resistance. CONCLUSION The results obtained indicate that the source of bacterial cell wall plays no part in the chemical or structural requirements for PG to induce chronic cell wall arthritis in the rats; the chemical structure of the PG moiety is decisive.